CLINICAL_TRIALS
trial_result
· 2023-06-15
Clinical Trial Update: Buspirone for Early Satiety and Symptoms of Gastroparesis [Phase 2]
Summary
Phase 2 trial investigating buspirone for early satiety and symptoms of gastroparesis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Gastroparesis | Phase 2 | Status: COMPLETED | Results posted: 2023-06-15